COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection

In March 2020, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was declared a global pandemic by the World Health Organization (WHO). The clinical course of the disease is unpredictable but may lead to severe acute respiratory infection (SARI) and pneumonia leading to acute respiratory dist...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pharmaceuticals (Basel)
Autori principali: Kotfis, Katarzyna, Lechowicz, Kacper, Drożdżal, Sylwester, Niedźwiedzka-Rystwej, Paulina, Wojdacz, Tomasz K., Grywalska, Ewelina, Biernawska, Jowita, Wiśniewska, Magda, Parczewski, Miłosz
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7830835/
https://ncbi.nlm.nih.gov/pubmed/33477294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14010071
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi